MedMen controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile3 entries
2024
Regulatory suspension and bankruptcy
MedMen securities were suspended by Canadian regulators and subsequently delisted. The company later entered bankruptcy proceedings in Canada, while its U.S. operation filed for Chapter 7 liquidation and ceased operations.
2019
Wrongful-discharge lawsuit and executive departures
Former CFO James Parker sued MedMen, alleging wrongful discharge. The company and its CEO denied the claims and described them as baseless. Around the same period, the COO, general counsel, and senior communications executive resigned. The dispute contributed to the New York Medical Cannabis Industry Association removing MedMen from its roster.
2019
Criticism of cannabis advertising claims
The Journal of the American Medical Association cited MedMen’s nationally broadcast health-related cannabis claims while calling for a national evidence-based regulatory framework for marijuana marketing.